Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+23.2%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+8.3%/yr
vs +98.3%/yr prior
5Y CAGR
+23.2%/yr
Recent deceleration
Acceleration
-90.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$388.30M+19.5%
2024$324.94M+8.1%
2023$300.71M-1.5%
2022$305.31M+47.8%
2021$206.53M+51.1%
2020$136.65M+216.8%
2019$43.13M+118.6%
2018$19.73M+380.6%
2017$4.11M-